MedTrace Logo

Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop

NCT06732830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-04-01

No results posted yet for this study

Summary

Clinical trial conducted with the aim of evaluating changes in the signs of dry eye through the change in the amount of tears produced, measured through the Schirmer test. It will be performed in 45 patients diagnosed with mild/moderate dry eye who meet the inclusion/exclusion criteria. Follow-up will be 12 weeks with a maximum of 4 visits.

Conditions

  • Dry Eye Syndrome

Interventions

DEVICE

DayDrop Advanced ophthalmic drop

The patient will administer 1 or 2 drops of DayDrop Advanced in each eye 3 times a day for 3 months.

Sponsors & Collaborators

  • Bioaraba Health Research Institute

    collaborator NETWORK

  • i+Med S.Coop.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-21
Primary Completion
2023-09-25
Completion
2023-09-25

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06732830 on ClinicalTrials.gov